FMR LLC
Institutional investor · Portfolio as of Q2 2024
Top Holdings5,362 positions
NVIDIA CORP | 1B | $129B | 8.3% | — | — | — | Increased 100 |
MICROSOFT CORP | 216.7M | $96.8B | 6.2% | — | — | — | Decreased 0 |
APPLE INC | 345.6M | $72.8B | 4.7% | — | — | — | Increased 69 |
FACEBOOK INC | 138.5M | $69.8B | 4.5% | — | — | — | Increased 59 |
AMAZON COM INC | 329.3M | $63.6B | 4.1% | — | — | — | Increased 59 |
ALPHABET INC | 228.4M | $41.6B | 2.7% | — | — | — | Increased 55 |
LILLY ELI & CO | 33.5M | $30.3B | 1.9% | — | — | — | Decreased 0 |
BERKSHIRE HATHAWAY INC DEL | 33,428 | $20.5B | 1.3% | — | — | — | Unchanged 0 |
ALPHABET INC | 109.1M | $20B | 1.3% | — | — | — | Increased 50 |
EXXON MOBIL CORP | 151.5M | $17.4B | 1.1% | — | — | — | Increased 53 |
UNITEDHEALTH GROUP INC | 32.7M | $16.7B | 1.1% | — | — | — | Decreased 0 |
NETFLIX INC | 21.2M | $14.3B | 0.9% | — | — | — | Increased 45 |
VISA INC | 53.8M | $14.1B | 0.9% | — | — | — | Increased 46 |
BROADCOM INC | 7.4M | $11.9B | 0.8% | — | — | — | Increased 56 |
WELLS FARGO CO NEW | 189.1M | $11.2B | 0.7% | — | — | — | Increased 45 |
REGENERON PHARMACEUTICALS | 10.6M | $11.2B | 0.7% | — | — | — | Decreased 0 |
BOSTON SCIENTIFIC CORP | 141.5M | $10.9B | 0.7% | — | — | — | Decreased 0 |
GENERAL ELECTRIC CO | 67.7M | $10.8B | 0.7% | — | — | — | Decreased 0 |
JPMORGAN CHASE & CO | 53.1M | $10.7B | 0.7% | — | — | — | Decreased 0 |
MASTERCARD INC | 20.7M | $9.1B | 0.6% | — | — | — | Decreased 0 |
FMR LLC manages $1.6T across 5362 positions as of Q2 2024. Top holdings: NVDA (8.3%), MSFT (6.2%), AAPL (4.7%). Fund DNA: Balanced Allocator. HoldingsIntel Score: 3/5.0.
Active quarter - 464 new positions, 455 exits, 2684 increased. Top move: NVDA (INCREASED, conviction 100). Portfolio: $1.6T across 5362 positions.
Top holdings by portfolio weight
Portfolio allocation by GICS sector
Behavioral investing profile
Similar Funds
Funds with similar investing DNA
Explore More
Accumulation Streaks
Positions with 2+ consecutive quarters of increases - persistent directional conviction.
Continue exploring
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer
Verify source filings on SEC EDGAR